NCT06536010View on ClinicalTrials.gov

Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2028

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Venetoclax 100 mg d1，200 mg d2，400 mg d3-28；

VAG in the induction phase of the ND-AML treatment protocol

Trial Locations (1)

210000

RECRUITING

Huai'an Second People's Hospital, Huai'an

All Listed Sponsors
lead

Yang Xiaotian

OTHER